Tian'an Pharmaceutical Co., Ltd.
TNPH · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $6 | $1 | $2 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $6 | $1 | $2 | $4 |
| Property Plant & Equip (Net) | $0 | $0 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6 | $1 | $4 | $5 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $62 | $55 | $54 | $53 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $30 | $41 | $41 | $39 |
| Total Curr. Liab. | $91 | $95 | $94 | $93 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $91 | $95 | $94 | $93 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $800 | $800 | $800 | $800 |
| Retained Earnings | -$7,601 | -$7,610 | -$7,606 | -$7,603 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $6,716 | $0 |
| Total Equity | -$86 | -$94 | -$91 | -$88 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6 | $1 | $4 | $5 |
| Net Debt | $62 | $55 | $54 | $53 |